All4NutraNo products in the cart.
All4NutraStartseite » News » Dry Powder Inhalers (DPI) » Page 13
Capsule-based, single-dose dry powder inhalers (DPIs) are commonly-used devices to deliver medications to the lungs. This work evaluates the effect of the...
Commercially available dry powder inhalers (DPIs) are usually devices in a fixed combination with the intended formulation, and a change...
Spray drying is a particle engineering technique used to manufacture respirable pharmaceutical powders that are suitable for delivery to the...
Meggle took a closer look at the multi-functional excipient lactose. Have a look at the background information for lactose as...
AS01B is a liposomal formulation of two immunostimulants namely 3-O-desacyl-4́-monophosphoryl lipid A (MPL) and QS-21. The liposomal formulation of AS01B...
Dry powder inhalation offers a well-established administration route for either local or systemic drug delivery. Lactose-based powder blends still build...
Currently marketed dry powder inhaler (DPI) medicine lacks drug delivery performance due to insufficient powder dispersion. In carrier-based blends, incomplete...
The last half century of pulmonary product development is reviewed in the context of the main drivers of innovation, technology...
It has been hypothesized that simvastatin could be used to treat pulmonary arterial hypertension (PAH). This study is intended to...
The study documents the flower-like lactose particles as potential carriers to improve Dry Powder Inhaler (DPI) efficiency. The lactose particles...
Copyright: PharmaExcipients AG